Alnylam Pharmaceuticals Inc (ALNY) financials · P/E 37, rev $3.71B
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Alnylam Pharmaceuticals Inc (ALNY) P/E 37, rev $3.71B.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $3.71B | $2.25B |
| Cost of Revenue | $677.2M | $306.5M |
| Gross Profit | $3.04B | $1.94B |
| Operating Income | $501.6M | -$176.9M |
| Net Income | $313.7M | -$278.2M |
| EPS (Diluted) | $2.33 | -$2.18 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $4.97B | $4.24B |
| Current Assets | $4.05B | $3.30B |
| Cash & Equivalents | $1.66B | $966.4M |
| Inventory | $82.7M | $78.5M |
| PP&E | $513.1M | $502.8M |
| Total Liabilities | $4.18B | $4.17B |
| Current Liabilities | $1.47B | $1.19B |
| Shareholders' Equity | $789.2M | $67.1M |
| Retained Earnings | -$6.70B | -$7.29B |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $524.1M | -$8.31M |
| CapEx | $58.7M | $34.3M |
| Investing Cash Flow | $436.3M | -$116.8M |
| Financing Cash Flow | -$305.2M | $294.2M |
| Net Change in Cash | $690.2M | $153.8M |
| Free Cash Flow | $465.4M | -$42.6M |
FAQ
What is ALNY P/E and revenue?
Alnylam Pharmaceuticals Inc (ALNY) P/E 37, rev $3.71B.
What is ALNY revenue?
Alnylam Pharmaceuticals Inc last cached revenue is $3.71B (FY2025).
Is ALNY profitable?
Alnylam Pharmaceuticals Inc last cached net income is $313.7M (FY2025).
What are ALNY total assets?
Alnylam Pharmaceuticals Inc last cached total assets are $4.97B (FY2025).
What is ALNY free cash flow?
Alnylam Pharmaceuticals Inc last cached free cash flow is $465.4M (FY2025).
Not investment advice. Cached statements, not a live tape.